National Cancer Institute, Research Contracts Branch, PCCS, Executive Plaza South, Room 635, Bethesda, Md 20892

A -- PRECLINICAL EVALUATION OF INTERMEDIATE ENDPOINTS AND THEIR MODULATION BY CHEMOPREVENTIVE AGENTS SOL MAA RFP NCI-CN-75031-72 DUE 120197 POC Jacqueline Ballard, Contracting Officer, NCI, RCB, PCCS, 301-435-3795 or Email: ballardj@rcb.nci.nih.gov. E-MAIL: Ballard, Jacques, ballardj@rcb.nci.nih.gov. ALL OFFERORS: The purpose of this modification to the referenced solicitation is to amend page 44, Section d., Evaluation Factors for Award to read as follows: d. Evaluation Factors For Award, Paragraph 2., is revised to delete Subparagraphs a. and b. as follows: 2. MANDATORY QUALIFICATION CRITERIA: Listed below are mandatory qualification criteria, if applicable, and evaluation criteria. The qualification criteria establishes conditions that must be met in order for your proposal to be considered. c. The animal facilities shall comply with NIH guidelines as stated in the Guide for Care and Use of Laboratory Animal, NIH Publication #86-23, 1985 and as updated, and with Public Law 91-579 of December 24, 1970. It is desired that the laboratory be American Association for Accreditation of Laboratory Animal Care (AAALAC) accredited, USDA and OPRR registered, and demonstrate an active Institutional Animal Care and Use Committee. Purpose: Subparagraphs a and b were inadvertently included as a "Mandatory requirement." Responses to MAA RFP NCI-CN-75031-72 are due by close of business on December 1, 1997 at 3:00 p.m. to Jacqueline Ballard, Contracting Officer, National Cancer Institute, EPS/635, 6120 Executive Blvd., MCS 7226, Bethesda, Md 20892-7226. Direct all inquires to 301-435-3795. (0290)

Loren Data Corp. http://www.ld.com (SYN# 0003 19971021\A-0003.SOL)